Search Results - "MONTINE, KATHLEEN S"

Refine Results
  1. 1

    Brain proteomic analysis implicates actin filament processes and injury response in resilience to Alzheimer’s disease by Huang, Zhi, Merrihew, Gennifer E., Larson, Eric B., Park, Jea, Plubell, Deanna, Fox, Edward J., Montine, Kathleen S., Latimer, Caitlin S., Dirk Keene, C., Zou, James Y., MacCoss, Michael J., Montine, Thomas J.

    Published in Nature communications (12-05-2023)
    “…Resilience to Alzheimer’s disease is an uncommon combination of high disease burden without dementia that offers valuable insights into limiting clinical…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Understanding the molecular basis of resilience to Alzheimer's disease by Montine, Kathleen S, Berson, Eloïse, Phongpreecha, Thanaphong, Huang, Zhi, Aghaeepour, Nima, Zou, James Y, MacCoss, Michael J, Montine, Thomas J

    Published in Frontiers in neuroscience (19-12-2023)
    “…The cellular and molecular distinction between brain aging and neurodegenerative disease begins to blur in the oldest old. Approximately 15-25% of observations…”
    Get full text
    Journal Article
  4. 4

    Mass synaptometry: High-dimensional multi parametric assay for single synapses by Gajera, Chandresh R., Fernandez, Rosemary, Postupna, Nadia, Montine, Kathleen S., Fox, Edward J., Tebaykin, Dmitry, Angelo, Michael, Bendall, Sean C., Keene, C. Dirk, Montine, Thomas J.

    Published in Journal of neuroscience methods (15-01-2019)
    “…•Mass synaptometry method for single synapse multiplexed molecular profiling.•Synapse by Time Of Flight (SynTOF) panel of 34 antibodies for wide…”
    Get full text
    Journal Article
  5. 5

    Prostaglandin E2 Receptor Subtype 2 Regulation of Scavenger Receptor CD36 Modulates Microglial Aβ42 Phagocytosis by Li, Xianwu, Melief, Erica, Postupna, Nadia, Montine, Kathleen S, Keene, C. Dirk, Montine, Thomas J

    Published in The American journal of pathology (2015)
    “…Recent studies underline the potential relevance of microglial innate immune activation in Alzheimer disease. Primary mouse microglia that lack prostaglandin…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    TDP-43 Neuropathologic Associations in the Nun Study and the Honolulu-Asia Aging Study by Flanagan, Margaret E, Cholerton, Brenna, Latimer, Caitlin S, Hemmy, Laura S, Edland, Steven D, Montine, Kathleen S, White, Lon R, Montine, Thomas J

    Published in Journal of Alzheimer's disease (01-01-2018)
    “…Transactive response binding protein-43 (TDP-43) cytoplasmic neuronal and glial aggregates (pathologic TDP-43) have been described in multiple brain diseases…”
    Get more information
    Journal Article
  9. 9
  10. 10

    Adult Changes in Thought study: dementia is an individually varying convergent syndrome with prevalent clinically silent diseases that may be modified by some commonly used therapeutics by Montine, Thomas J, Sonnen, Joshua A, Montine, Kathleen S, Crane, Paul K, Larson, Eric B

    Published in Current Alzheimer research (01-07-2012)
    “…The Adult Changes in Thought (ACT) study is a longitudinal population-based prospective cohort study of brain aging and incident dementia in the Seattle…”
    Get more information
    Journal Article
  11. 11
  12. 12

    Proteomic analysis of neurofibrillary tangles in Alzheimer disease identifies GAPDH as a detergent-insoluble paired helical filament tau binding protein by Wang, Qin, Woltjer, Randall L, Cimino, P. J, Pan, Catherine, Montine, Kathleen S, Zhang, Jing, Montine, Thomas J

    Published in The FASEB journal (01-05-2005)
    “…ABSTRACT We performed proteomic analysis of neurofibrillary tangles (NFTs) obtained by laser capture microdissection from pyramidal neurons in hippocampal…”
    Get full text
    Journal Article
  13. 13

    Biomarkers for cognitive impairment and dementia in elderly people by Sonnen, Joshua A, MD, Montine, Kathleen S, PhD, Quinn, Joseph F, MD, Kaye, Jeffrey A, MD, Breitner, John CS, MD, Montine, Thomas J, MD

    Published in Lancet neurology (01-08-2008)
    “…Summary The threat of a looming pandemic of dementia in elderly people highlights the compelling need for the development and validation of biomarkers that can…”
    Get full text
    Journal Article
  14. 14

    Unveiling Resilience to Alzheimer’s Disease: Insights From Brain Regional Proteomic Markers by Huang, Zhi, Merrihew, Gennifer E, Larson, Eric B, Park, Jea, Plubell, Deanna, Fox, Edward J, Montine, Kathleen S, Keene, C Dirk, Latimer, Caitlin S, Zou, James Y, MacCoss, Michael J, Montine, Thomas J

    Published in Journal of experimental neuroscience (01-01-2023)
    “…Studying proteomics data of the human brain could offer numerous insights into unraveling the signature of resilience to Alzheimer’s disease. In our previous…”
    Get full text
    Journal Article
  15. 15

    Apolipoprotein C-I is an APOE genotype-dependent suppressor of glial activation by Cudaback, Eiron, Li, Xianwu, Yang, Yue, Yoo, Thomas, Montine, Kathleen S, Craft, Suzanne, Montine, Thomas J, Keene, Christopher Dirk

    Published in Journal of neuroinflammation (10-08-2012)
    “…Inheritance of the human ε4 allele of the apolipoprotein (apo) E gene (APOE) significantly increases the risk of developing Alzheimer's disease (AD), in…”
    Get full text
    Journal Article
  16. 16

    Prostaglandin E2 receptor subtype 2 (EP2) regulates microglial activation and associated neurotoxicity induced by aggregated alpha-synuclein by Jin, Jinghua, Shie, Feng-Shiun, Liu, Jun, Wang, Yan, Davis, Jeanne, Schantz, Aimee M, Montine, Kathleen S, Montine, Thomas J, Zhang, Jing

    Published in Journal of neuroinflammation (04-01-2007)
    “…The pathogenesis of idiopathic Parkinson's disease (PD) remains elusive, although evidence has suggested that neuroinflammation characterized by activation of…”
    Get full text
    Journal Article
  17. 17

    Microglial EP2 is critical to neurotoxicity from activated cerebral innate immunity by Shie, Feng-Shiun, Montine, Kathleen S., Breyer, Richard M., Montine, Thomas J.

    Published in Glia (01-10-2005)
    “…Prostaglandin (PG) E2 acts via four functionally antagonistic E‐prostanoid (EP) receptors that are expressed on multiple cell types in the nervous system;…”
    Get full text
    Journal Article
  18. 18

    Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases by Montine, Kathleen S, Quinn, Joseph F, Zhang, Jing, Fessel, Joshua P, Roberts, L.Jackson, Morrow, Jason D, Montine, Thomas J

    Published in Chemistry and Physics of Lipids (01-03-2004)
    “…Lipid peroxidation is a major outcome of free radical-mediated injury to brain, where it directly damages membranes and generates a number of oxidized…”
    Get full text
    Book Review Journal Article
  19. 19
  20. 20